In a letter to Judge Lewis Kaplan, defense attorney Mark Cohen said his client “has been doing his best to remain focused during the trial” despite receiving inadequate doses of Adderall from the Bureau of Prisons (BOP).
“However, as we approach the defense case and the critical decision of whether Mr. Bankman-Fried will testify, the defense has a growing concern that because of Mr. Bankman-Fried’s lack of access to Adderall he has not been able to concentrate at the level he ordinarily would and that he will not be able to meaningfully participate in the presentation of the defense case,” Cohen wrote.
‘Enforcement 40’ for 2020
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn